{"id":18402,"date":"2021-06-29T08:07:14","date_gmt":"2021-06-29T12:07:14","guid":{"rendered":"https:\/\/medicarereport.org\/?p=18402"},"modified":"2021-06-29T08:07:14","modified_gmt":"2021-06-29T12:07:14","slug":"medicare-could-limit-who-gets-new-alzheimers-drug","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=18402","title":{"rendered":"Medicare could limit who gets new Alzheimer&#8217;s drug"},"content":{"rendered":"<p>(By\u00a0Lauren Jensik for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n<p>Medicare members could face barriers to accessing Biogen&#8217;s new Alzheimer&#8217;s drug, Aduhelm, due to the treatment&#8217;s high cost.\u00a0 Read the article <a href=\"https:\/\/www.beckershospitalreview.com\/payer-issues\/medicare-could-limit-who-gets-new-alzheimer-s-drug.html\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/10\/Medicare.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4820\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/10\/Medicare-300x181.png\" alt=\"\" width=\"300\" height=\"181\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/10\/Medicare-300x181.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/10\/Medicare.png 544w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By\u00a0Lauren Jensik for Becker&#8217;s Hospital Review) Medicare members could face barriers to accessing Biogen&#8217;s new Alzheimer&#8217;s drug, Aduhelm, due to<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,6,15],"tags":[],"class_list":["post-18402","post","type-post","status-publish","format-standard","hentry","category-alzheimersdementia","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18402"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18402\/revisions"}],"predecessor-version":[{"id":18403,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18402\/revisions\/18403"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}